Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol PK for Anti-Doping Detection
NCT05925686Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Jun 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tramadol in pain, sponsored by Parc de Salut Mar. Primary endpoint: Urine concentration on Tramadol at 8 hours. Started Jun 2023; status: completed.
02
Drugs
tramadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT05925686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05925686.